Compare ANDE & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANDE | BLFS |
|---|---|---|
| Founded | 1947 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 2005 | 2013 |
| Metric | ANDE | BLFS |
|---|---|---|
| Price | $66.66 | $38.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 9 |
| Target Price | ★ $88.33 | $31.29 |
| AVG Volume (30 Days) | 275.0K | ★ 1.1M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | ★ 2.62 | 0.94 |
| Revenue | ★ $11,008,928,000.00 | $96,214,000.00 |
| Revenue This Year | $5.61 | $19.76 |
| Revenue Next Year | $2.38 | $17.03 |
| P/E Ratio | ★ $25.15 | $41.07 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $40.81 | $17.86 |
| 52 Week High | $82.11 | $39.76 |
| Indicator | ANDE | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 47.88 | 59.61 |
| Support Level | $65.98 | $34.38 |
| Resistance Level | $71.56 | N/A |
| Average True Range (ATR) | 1.83 | 1.10 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 38.56 | 72.94 |
Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.